WHO’S GETTING FUNDED
Gemstone Biotherapeutics followed up its Maryland Incubator Company of the Year award with new funding. The Hopkins-affiliated startup raised $1.6 million, bringing the company’s seed funding total to $2.45 million. The company is developing technology to help wounds heal through skin regeneration. Tests on burns showed no scarring left behind.
Pixelligent closed on $3.4 million in funding. The company will use the new money to ramp up manufacturing of its nanocrystal technology, which is used in LED and other types of lighting.
Columbia-based Chiron landed a $10.7 million U.S. government IT contract. The cybersecurity firm will develop physical and virtual IT systems that can analyze sensitive data that is considered “mission critical.”
WHO’S MAKING MOVES
Sickweather is expanding its illness-tracking capability to other apps. The ETC-based startup developed an API that can be used by others, and the first to take advantage is HEALTHYDAY, which was released by a division of Johnson & Johnson. Mashable featured the app’s capability, but curiously neglected to mention Sickweather.
Yet Analytics formally launched YetCore, its open platform that helps interoperability of training data across systems, devices, wearables, IoT and whatever else comes along. We caught up with cofounders Shelly Blake-Plock and Margaret Roth earlier this year for a full explanation of the platform, and its roots in a Department of Defense API.
The Chesapeake Regional Tech Council is seeking a new executive director. Kris Valerio Shock resigned her post after seven years with the regional organization, and her last day will be June 30. Shock took a job as Senior Account Director with PR and marketing firm Exit10, which has offices in the Camden Yards Warehouse. Shock’s role will have an emphasis on Corporate Social Responsibility. She notes that the firm is already a CRTC member.
The CRTC also named Heather East as Director of Membership and Operations.
Baltimore-based digital marketing company Enradius signed HEX Performance as a new client. The company makes cleaning products for athletes and generally “those who sweat.” Enradius will target potential HEX users in Charlotte, N.C., and Rochester, N.Y.
Symbiomix Therapeutics began Phase 3 testing of its treatment for bacterial vaginosis. The trial will enroll at least 180 women across about 20 sites across the country. The company, which has an office in ETC, makes a candidate single-dose treatment for BV.
WHO’S GETTING BUZZ
Kelly Keenan-Trumpbour was the subject of a Baltimore Sun profile that focused on her efforts to invest in companies run by women. Reporter Carrie Wells also checked in with Greg Cangialosi and Allovue’s Jess Gartner for their thoughts on Trumpbour.